NGM Biopharmaceuticals · 11 hours ago
Clinical Contracts Manager
NGM Biopharmaceuticals, Inc. is a privately held biotechnology company focused on discovering and developing novel medicines. They are seeking a Clinical Contracts Manager who will manage the contracting process, lead negotiations, and ensure effective communication with various stakeholders.
BiopharmaBiotechnologyGeneticsMedical
Responsibilities
Managing the contracting process from the initial contract request through full execution. This requires an understanding of risk mitigation methodology, risk analysis for contracts review and negotiation, and best practices for business contracts
Leading and contributing to contract negotiations; preparing for discussions based on best solutions and desired outcomes, and determining the minimum requirements for acceptance based on Company’s legal guidelines
Drafting original contracts and template agreements related to clinical trials and associated services
Drafting and reviewing agreements including, but not limited to: Confidentiality, Consulting Services, Clinical Trial related, CRO services, Master Services, and Work Orders and Amendments/Change Orders
Communicating effectively with contract research organizations (CROs) and contract manufacturing organizations (CMOs) and other vendors to manage services and budget changes in the provision of services on Company’s behalf
Tracking in-progress agreements and follow up with vendors for status
Acting as the primary contact between the project team and/or business unit and the external party, ensuring that all contractual matters are addressed efficiently and promptly
Ensuring timely response to complex inquiries regarding contract obligations and revisions
Escalating and delegating to appropriate teammates in a timely and thoughtful way
Communicating effectively with the internal customers to escalate matters as appropriate for expert review
Developing strong working relationships with functional groups and project teams
Managing a queue of assigned contracts in the electronic contracts management database system, working as a System Administrator to support NGM’s on-premise contracts management database
Ensuring data integrity, and that the data fields and status in the system are updated in real time, based on contract negotiations and status change activity
Special projects and miscellaneous tasks as business needs dictate
Qualification
Required
Substantive experience in the contracts management field (preferably in a pharmaceutical environment performing contracts management duties)
Prior experience with autonomous contract drafting and negotiation
The personality and ability to perform due diligence research with enthusiasm
The ability to apply critical thinking and analysis as it relates to contracts matters
Proficiency with the Microsoft Office suite (Word, Excel, PowerPoint)
Excellent written and verbal communication skills; ability to work effectively and efficiently with all levels of management and personnel
Ability to quickly comprehend, prioritize and manage business contracts and other complex documents in a short timeframe
Project Management skills, specifically strong organizational and planning skills, meticulous attention to detail, ability to manage changing priorities and workflow, and the ability to effectively advance multiple simultaneous projects
Ability to work independently while exercising initiative and good judgment
Conscientious diligent worker
Self-motivated starter
Versatility, flexibility, and enthusiasm
Company
NGM Biopharmaceuticals
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
H1B Sponsorship
NGM Biopharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (1)
2024 (2)
2023 (6)
2022 (5)
2021 (4)
2020 (7)
Funding
Current Stage
Growth StageTotal Funding
$542.44MKey Investors
The Column GroupMerck
2024-07-17Series A· $122M
2021-01-06Post Ipo Equity· $125M
2019-04-04IPO
Leadership Team
Recent News
EIN Presswire
2025-05-17
Company data provided by crunchbase